Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. 1988

A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
Department of Internal Medicine, Virgen del Rocío Hospital, Seville, Spain.

To evaluate the effectiveness of immune serum globulin (ISG) in preventing non-A, non-B hepatitis, 291 heart surgery patients who received blood from voluntary donors were randomly assigned to receive either ISG or no additional protection. ISG was given intramuscularly before and 1 week after transfusion. 98 controls and 100 in the ISG group completed the study. Post-transfusion non-A, non-B hepatitis developed in 11 (11.2%) controls but in only 3 (3.0%) of the ISG group (p = 0.0203). 8 (72.7%) of control group with hepatitis had symptoms, and in 5 (45.4%) the disease became chronic. The disease was self-limiting in all 3 ISG patients affected, and only 1 of them had symptoms. Among those with non-A, non-B hepatitis aminotransferase levels were higher in the controls than in the ISG patients. Incubation periods longer than 8 weeks correlated with a tendency for the disease to become chronic. ISG recipients had shorter as well as more homogeneous incubation periods. ISG could be a safe, low-cost means for preventing post-transfusion non-A, non-B hepatitis which does not call for the discarding of donated blood.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
October 1988, Revue francaise de transfusion et immuno-hematologie,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
November 1984, Lancet (London, England),
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
June 1992, Infusionstherapie und Transfusionsmedizin,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
January 1995, Lancet (London, England),
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
November 1987, Zhonghua nei ke za zhi,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
March 1977, Lancet (London, England),
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
February 1985, Gematologiia i transfuziologiia,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
January 1989, Beitrage zur Infusionstherapie = Contributions to infusion therapy,
A Sánchez-Quijano, and J A Pineda, and E Lissen, and M Leal, and M A Díaz-Torres, and F García De Pesquera, and F Rivera, and R Castro, and J Muñoz
September 1984, Orvosi hetilap,
Copied contents to your clipboard!